ANTRUK
UK government’s AMR study highlights importance of appropriate antibiotic use
The UKHSA found that some bacteria are already becoming resistant to ceftazidime/avibactam
New genomic technique could improve antibiotic-resistant bacteria tracking in hospitals
The sequencing method is able to track the spread of multiple bacteria at the same time
WHO updates drug-resistant bacteria list to develop new treatments for AMR
The 2024 BPPL list includes 15 families of antibiotic-resistant bacteria
NICE recommends better targeting of antibiotics for suspected sepsis
It is hoped that the new guidance will reduce the risk of antibiotic resistance by ensuring antibiotics are targeted to those at the greatest risk
New antibiotic compound could potentially treat lethal hospital infections
Zosurabalpin successfully eliminated the multi-resistant A baumannii bacteria
MIT researchers identify new class of antibiotic candidates using AI
MRSA is a drug-resistant bacterium responsible for 10,000 deaths a year in the US
National surveillance data reveals increase in antibiotic resistant infections in England
The number of deaths due to severe antibiotic resistant infections also increased in 2022
Shionogi, GARDP and CHAI team up to increase antibiotic access worldwide
The licence and collaboration agreements will provide 135 countries access to cefiderocol
Antibiotic resistance: The silent pandemic
Porterhouse is proud to support World Antibiotic Awareness Week. Our article aims to improve awareness of one of the biggest threats to global health today: antibiotic resistance.
Shionogi scores FDA approval for new cUTI antibiotic
Pivotal new treatment for adults with complicated urinary tract infection
Labour Party takes aim at pharma, calls attention to Orkambi row
Proposal to introduce compulsory licensing faces industry criticism
Boris Johnson is new PM – but opposition to his Brexit plans mount
Brexit rhetoric unrealistic, suggests biotech leader